切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 137 -143. doi: 10.3877/cma.j.issn.1674-134X.2020.02.002

所属专题: 文献

临床论著

富血小板血浆对膝骨关节炎相关细胞因子的影响
曾佳森1, 张亚勤2, 周亮1, 林万昌3, 陈宏斌3, 张剑平1, 陈智彪1, 徐维臻1, 黄宇敏1, 林伟长1, 陈朝显1   
  1. 1. 363000 厦门大学附属东南医院(解放军第909医院)全军骨科中心,福建省漳州市解放军第909医院骨科医院
    2. 363000 厦门大学附属东南医院(解放军第909医院)麻醉科
    3. 361005 厦门大学医学院
  • 收稿日期:2019-02-02 出版日期:2020-04-01
  • 基金资助:
    南京军区医学科技创新重点课题项目(15ZD027)

Curative effect of platelet-rich plasma in treatment of knee osteoarthritis and influences on serum cytokines levels

Jiasen Zeng1, Yaqin Zhang2, Liang Zhou1, Wanchang Lin3, Hongbin Chen3, Jianping Zhang1, Zhibiao Chen1, Weizhen Xu1, Yumin Huang1, Weichang Lin1, Chaoxian Chen1   

  1. 1. Orthopedic Center of PLA, Southeast Hospital Affiliated to Xiamen University, the 909th Hospital of PLA, Zhangzhou 363000, China
    2. Anesthesiology Department, Southeast Hospital Affiliated to Xiamen University, the 909th Hospital of PLA, Xiamen 363000, China
    3. Medical College of Xiamen University, Xiamen 361005, China
  • Received:2019-02-02 Published:2020-04-01
  • About author:
    Corresponding author: Zhai Wenliang, Email:
引用本文:

曾佳森, 张亚勤, 周亮, 林万昌, 陈宏斌, 张剑平, 陈智彪, 徐维臻, 黄宇敏, 林伟长, 陈朝显. 富血小板血浆对膝骨关节炎相关细胞因子的影响[J/OL]. 中华关节外科杂志(电子版), 2020, 14(02): 137-143.

Jiasen Zeng, Yaqin Zhang, Liang Zhou, Wanchang Lin, Hongbin Chen, Jianping Zhang, Zhibiao Chen, Weizhen Xu, Yumin Huang, Weichang Lin, Chaoxian Chen. Curative effect of platelet-rich plasma in treatment of knee osteoarthritis and influences on serum cytokines levels[J/OL]. Chinese Journal of Joint Surgery(Electronic Edition), 2020, 14(02): 137-143.

目的

探讨富血小板血浆治疗膝骨关节炎(OA)的临床疗效及其对血清白细胞介素- 1β(IL-1β)、白细胞介素- 6(IL-6)、基质金属蛋白酶- 9(MMP- 9)、基质金属蛋白酶- 13(MMP-13)、肿瘤坏死因子- α(TNF-α)水平的影响。

方法

招募于2017年1月至5月单号选择漳州市解放军第909医院门诊就诊的膝关节OA患者符合Kellgren-Lawrence(K-L)分级(Ⅱ~Ⅲ级)分级标准设置为富血小板血浆(PRP)组40例,双号选择漳州市解放军第909医院门诊就诊的膝关节OA患者符合K-L分级(Ⅱ~Ⅲ级)分级标准设置为透明质酸钠(SH)组40例,招募后统计两组患者年龄平均(53±3)岁,其中男33例,女47例;左膝35例,右膝45例,分别采用PRP和SH关节腔内注射进行治疗。两组患者于治疗前及首次治疗后3、6、12个月,通过视觉模拟评分(VAS),西安大略麦马斯特大学骨关节炎指数可视化量表(WOMAC)及膝关节X线总评分以评估临床疗效,酶联免疫法检测血清IL-1β、IL-6、MMP- 9、MMP-13、TNF-α含量的变化,两组间各时间点比较采用t检验,两组内各时间点比较采用重复测量方差分析。

结果

80例患者中,77例完成随访,PRP组39例,SH组38例。两组患者治疗前WOMAC分级评分、膝关节X线总评分,血清中细胞因子的表达水平无统计学意义(P>0.05)。与治疗前相比,PRP组治疗3、6个月后患者的VAS评分,WOMAC评分,膝关节X线总评分,血清IL-1β、IL-6、MMP- 9、MMP-13、TNF-α含量均降低,差异均有统计学意义(t值分别为:1.14、4.673、0.410、9.852、7.845、12.03、6.108、11.66、11.34、13.89、9.779、15.83、13.71、28.84、7.182、27.76,均为P<0.05);与治疗前相比,SH组治疗后3、6、12个月治疗后膝关节X线总评分,血清IL-1β、IL-6、MMP- 9、MMP13、TNF-α含量无明显改变,差异无统计学意义(P>0.05);6、12个月两组患者的VAS评分,WOMAC评分,膝关节X线总评分,血清IL-1β、IL-6、MMP-9、MMP-13、TNF-α含量对比,PRP组表现明显优于SH组,差异具有统计学意义(t值为分别为:-5.316、-10.943、-9.804、-9.554、-11.829、-14.256、-11.664、-10.259、-13.732、-12.837、-15.708、-12.919、-28.607、-20.693、-27.623、-23.344,均为P<0.05)。

结论

膝关节腔内注射自体PRP与SH,近期效果类似,治疗6、12个月后临床效果优于透明质酸钠,能有效改善患者的疼痛,控制病情的迁延,降低分解性细胞因子表达水平,值得临床推广应用。

Objective

To observe the curative effect of platelet rich plasma (PRP)intra-articular injection in the treatment of knee osteoart-hritis and the effect of serum interleukin (IL)- 1β、IL-6, matrix metalloprotein(MMP) -9 , MMP-13, tumor necrosis factor - α(TNF-α )level.

Methods

A total of 80 patients with knee osteoarthritis of grade Ⅱ and Ⅲ (Kellgren-Lawrence classification)were assigned to the platelet-rich plasma(PRP)and sodium hyaluronate(SH) group according to the date of consultation, 38 cases in SH group and 39 cases in PRP group had got the complete follow-up. Both the two groups adopted intra-articular injection.All the patients were prospectively evaluated before the treatment and at the third, sixth and 12th month after the treatment by the visual analogue scale(VAS) scores , the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index and the X-ray score of the knee.The changes of serum IL-1β、IL-6、MMP- 9、MMP-13、TNF-α were observed by enzyme-linked immunosorbent assay (ELISA). Between the two groups serum cytokines levels were compared using t test at each time point, within the groups the levels were compared by repeated measures analysis of variance.

Results

Among the 80 patients, 77 were followed up, 39 in PRP group, 38 in SH group. At the three, six and 12 months after the treatment, the levels of the cytokines, VAS, WOMAC and the X-ray scores of the PRP group were lower than before. There were significant differences between the two groups (t=1.14, 4.673, 0.410, 9.852, 7.845, 12.03, 6.108, 11.66, 11.34, 13.89, 9.779, 15.83, 13.71, 28.84, 7.182, 27.76, all P<0.05) .At the three, six and 12 months after the treatment, there was no significant change ofcytokinesand the X-ray score of the SH groups (t=-5.316, -10.943, -9.804, -9.554, -11.829, -14.256, -11.664, -10.259, -13.732, -12.837, -15.708, -12.919, -28.607, -20.693, -27.623, -23.344, all P>0.05) .No serious adverse event was detected in the two groups. According to the follow-up evaluations, both the groups presented clinical improvements at three months after the treatment.(P<0.05). The improvement of all above indexes in PRP group were more significant than those in SH group at the six and 12 months after the treatment (P<0.05).

Conclusion

PRP intra-articular injection has similar short-term effect compared with SH, while after six or 12 months of treatment, the clinical effect of PRP with superior pain relief is better than SH.

表1 两组患者性别、年龄、病程等一般资料比较
表2 两组膝OA患者治疗前后及各时间点间VAS评分比较[分,(±s)]
表3 两组患者治疗前后及各时间点间WOMAC评分比较[分,(±s)]
表4 两组患者治疗前后及各时间点间膝关节X线总评分比较[分,(±s)]
表5 两组患者治疗前后及各时间点间外周血IL-1β表达水平比较[ng/L,(±s)]
表6 两组患者治疗前后及各时间点间外周血IL-6表达水平比较[ng/L,(±s)]
表7 两组患者治疗前后各时间点外周血TNF-α表达水平比较[ng/L,(±s)]
表8 两组患者治疗前后及各时间点间外周血MMP-13表达水平比较[ng/L,(±s)]
表9 两组患者治疗前后及各时间点间外周血MMP-9表达水平比较[ng/L,(±s)]
[1]
Djurasovic M, Glassman SD, Carreon LY, et al. Contemporary management of symptomatic lumbar spinal stenosis[J]. Orthop Clin North Am, 2010, 41(2): 183-191.
[2]
Nakazawa F, Matsuno H, Yudoh K, et al. Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures[J]. Clin Exp Rheumatol, 2002, 20(6): 773-781.
[3]
Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis[J]. N Engl J Med, 2006, 354(8): 795-808.
[4]
邹国友,沈灏,王琦,等.人工关节假体多重菌和耐药菌感染对二期翻修手术的影响[J/CD].中华关节外科杂志(电子版),2012,6(6): 848-854.
[5]
翟文亮,周亮,刘晖,等.富血小板血浆与透明质酸钠治疗膝关节骨关节炎的临床观察[J/CD].中华关节外科杂志(电子版),2017,11(1): 96-100.
[6]
Piuzzi NS, Chughtai M, Khlopas A, et al. Platelet-Rich plasma for the treatment of knee osteoarthritis: a review[J]. J Knee Surg, 2017, 30(7): 627-633.
[7]
Dhollander AM, Neve FD, Almqvist KF, et al. Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report[J]. Knee Surg Sports Traumatol Arthrosc, 2011, 19(4): 536-542.
[8]
Alberto S, Mascaro G, Gentili C, et al. A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year[J]. Clin Orthop Relat Res, 2012, 470(3): 910-919.
[9]
谢雪涛,沈龙祥,陈圣宝,等.关节内注射富血小板血浆治疗膝骨关节炎的Meta分析[J/CD].中华关节外科杂志(电子版),2016,10(6): 636-644.
[10]
袁林,郭燕庆,于洪波,等.富血小板血浆治疗Ⅱ-Ⅲ期膝骨关节炎的疗效评价[J/CD].中华关节外科杂志(电子版),2016,10(4): 386-392.
[11]
Centers for Disease Control and Prevention(CDC). Incidence of end-stage renal disease among persons with diabetes—United States, 1990-2002[J]. MMWR Morb Mortal Wkly Rep. 2005,54(43): 1097-1100.
[12]
郭秦炜,田得祥,敖英芳.骨性关节炎关节软骨中Ⅰ型、Ⅱ型、Ⅲ型及Ⅹ型胶原的分布[J].中国运动医学杂志,2002,21(3): 228-231.
[13]
Chen C, Xie J, Rajappa R, et al. Interleukin-1β and tumor necrosis factor-α increase stiffness and impair contractile function of articular chondrocytes[J]. Acta Biochim Biophys Sin (Shanghai), 2015, 47(2): 121-129.
[14]
陈悦,赵明才.肿瘤坏死因子样凋亡微弱诱导剂在骨关节炎中的作用[J/CD].中华临床医师杂志(电子版),2011,5(18): 5392-5396.
[15]
Shlopov BV, Gumanovskaya ML, Hasty KA. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis[J]. Arthritis Rheum, 2000, 43(1): 195-205.
[16]
张长青,袁霆.富血小板血浆在临床应用中的争议与研究进展[J/CD].中华关节外科杂志(电子版),2016,10(6): 588-591.
[17]
Weibrich G, Kleis WK, Hafner G, et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count[J]. J Craniomaxillofac Surg, 2002, 30(2): 97-102.
[18]
Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma[J]. Am J Sports Med, 2011, 39(10): 2135-2140.
[19]
Deniz K, Arzu G, Akin A, et al. The effects of inflammatory response associated with traumatic spinal cord injury in cutaneous wound healing and on expression of transforming growth factor-beta1 (TGF-β1) and platelet-derived growth factor (PDGF)-A at the wound site in rats[J]. Growth Factors, 2008, 26(2): 74-79.
[20]
Solchaga LA, Penick K, Porter JD, et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells[J]. J Cell Physiol, 2005, 203(2): 398-409.
[21]
Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis[J]. Osteoarthritis Cartilage, 2006, 14(12): 1272-1280.
[22]
Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma from basic science to clinical applications[J]. Am J Sports Med, 2009, 37(11): 2259-2272.
[23]
Simon ES, Thomas SR. Bone and wound healing augmentation with platelet-rich plasma[J]. Clin Podiatr Med Surg, 2009, 26(4): 559-588.
[24]
邹国友,郑闽前,贾伟涛,等.富血小板血浆与透明质酸钠关节腔内注射治疗膝骨关节炎的疗效比较[J/CD].中华损伤与修复杂志(电子版),2014,9(6): 630-633.
[25]
Bastow ER, Byers S, Golub SB, et al. Hyaluronan synthesis and degradation in cartilage and bone[J]. Cell Mol Life Sci, 2008, 65(3): 395-413.
[26]
Cole BJ, Karas V, Hussey K, et al. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis[J]. Am J Sports Med, 2017, 45(2): 339-346.
[27]
哈承志,李伟,任少达,等.富血小板血浆联合间充质干细胞治疗膝骨关节炎的疗效[J/CD].中华关节外科杂志(电子版),2018,12(5): 644-652.
[1] 许银峰, 盛璞义, 余世明, 张阳春. 偏心性髋臼旋转截骨术治疗发育性髋关节发育不良[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 568-574.
[2] 马桥桥, 张传开, 郭开今, 蒋涛, 王子豪, 刘勇, 郝亮. 可降解止血粉减少初次全膝关节置换术失血量的研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 585-589.
[3] 刘鹏, 罗天, 许珂媛, 邓红美, 李瑄, 唐翠萍. 八段锦对膝关节炎疗效的初步步态分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 590-595.
[4] 李焕玺, 何淳诺, 田志敏, 周胜虎, 吴昊越, 张浩强. 全膝关节置换术后股骨远端假体周围骨折治疗现状[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 630-637.
[5] 王相迎, 杨长生, 曲铁兵. 固定平台单髁置换假体合适位置的研究进展[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 638-645.
[6] 苏介茂, 齐岩松, 王永祥, 魏宝刚, 马秉贤, 张鹏飞, 魏兴华, 徐永胜. 关节镜手术在早中期膝骨关节炎治疗的应用进展[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 646-652.
[7] 谢佳乐, 李琦, 芦升升, 姜劲松. 内侧膝骨关节炎伴胫股关节冠状半脱位的手术治疗[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 653-657.
[8] 郭艳波, 马亮, 李刚, 阎伟, 骆帝, 岳亮, 吴伟山. 全膝关节置换术后胫股关节脱位的研究进展[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 658-671.
[9] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[10] 王振宇, 张洪美, 荆琳, 何名江, 闫奇. 膝骨关节炎相关炎症因子与血浆代谢物间的因果关系及中介效应[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 467-473.
[11] 李亚龙, 王星童, 申传安. 异体富血小板血浆在创面修复中的临床应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 541-545.
[12] 赵芊, 李亚坤, 李智. 同种异体富血小板血浆临床应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 364-367.
[13] 宋庆成, 郑占乐, 王天瑞, 王宇钏, 张凯旋, 纳静, 蔚佳昊, 杨思繁, 宋九宏, 张英泽. “人老膝不老”:膝关节健康管理的全方位探索与实践[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 321-324.
[14] 郑占乐, 王宇钏, 蔚佳昊, 宋庆成, 张凯旋, 纳静, 王天瑞, 宋九宏, 张英泽, 王娟. 保膝须“开膝”——“开膝”在膝骨关节炎中的临床应用价值[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 325-330.
[15] 高广涵, 张耀南, 石磊, 王林, 王飞, 郑子天, 王鸿禹, 郭民政, 薛庆云. 膝骨关节炎患者前交叉韧带功能影像学影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 301-307.
阅读次数
全文


摘要